Coordinated effects of fibroblast growth factor-2 on expression of fibrillar collagens, matrix metalloproteinases, and tissue inhibitors of matrix metalloproteinases by human vascular smooth muscle cells: Evidence for repressed collagen production and activated degradative capacity

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 17, Issue 3, 1997, Pages 475-482

  Geoffrey Pickering, J ^a,b   Ford, Carol M ^a   Tang, Bao ^a   Chow, Lawrence H ^a  

^a ROBARTS RESEARCH INSTITUTE   (Canada)

^b LONDON HEALTH SCIENCES CENTRE   (Canada)

Author keywords

collagen; fibroblast growth factor; metalloproteinase; smooth muscle cells

Indexed keywords

COLLAGEN; COLLAGEN FIBER; COLLAGEN TYPE 1; COLLAGEN TYPE 3; COLLAGEN TYPE 5; COLLAGENASE; FIBROBLAST GROWTH FACTOR 2; GELATINASE A; GELATINASE B; MATRIX METALLOPROTEINASE; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE;

ARTICLE; ATHEROSCLEROTIC PLAQUE; BLOOD VESSEL INJURY; CELL PROLIFERATION; COLLAGEN SYNTHESIS; CONTROLLED STUDY; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SMOOTH MUSCLE FIBER; TISSUE REPAIR;

EID: 16944363654     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.atv.17.3.475     Document Type: Article

References (16)

1. Ross R, Klebanoff SJ. The smooth muscle cell, I: in vivo synthesis of connective tissue proteins. J Cell Biol. 1971;50:159-171.
2. Campbell G, Campbell J, Manderson J, Horrigan S, Rennick R. Arterial smooth muscle: a multifunctional mesenchymal cell. Arch Pathol Lab Med. 1988;112:977-986.
3. Ang A, Tachas G, Campbell J, Bateman J, Campbell G. Collagen synthesis by cultured rabbit aortic smooth-muscle cells: alteration with phenotype. Biochem J. 1990;265:461-469.
4. Barnes MJ. Collagens in atherosclerosis. Collagen Rel Res. 1985;5: 65-97.
5. Shekhonin BV, Domagatsky SP, Muzykantof VR, Idelson GY, Rukosuev VS. Distribution of type 1, III, IV and V collagen in normal and atherosclerotic human arterial wall: immunomor-phologic characteristics. Collagen Rel Res. 1985;5:355-368.
6. Murata K, Motayama T, Kotake C. Collagen types in various layers of the human aorta and their changes with the atherosclerotic process. Atherosclerosis. 1986;60:251-262.
7. Morton LF, Barnes MJ. Collagen polymorphism in the normal and diseased blood vessel wall: investigation of collagen types I, III, and V. Atherosclerosis. 1982;42:41-51.
8. Gross J, Nagai Y. Specific degradation of the collagen molecule by tadpole collagenolytic enzyme. Proc Natl Acad Sci USA. 1965;54: 1197-1204.
9. Netzel-Arnett S, Salari A, Goli UB, Van Wart HE. Evidence for a triple helix recognition site in the hemopexin-like domain of human fibroblast and neutrophil interstitial collagenases. Ann NY Acad Sci. 1994;732:22-30.
10. Weiss JB. Enzymatic degradation of collagen. In: Hall DA, Jackson DS, eds. International Review of Connective Tissue Research. New York, NY: Academic Press; 1976:102-149.
11. Galis ZS, Muszynski M, Sukhova GK, Simon-Morrissey E, Unemore EN, Lark MW, Amento E, Libby P. Cytokine-stimulated human vascular smooth muscle cells synthesize a compliment of enzymes required for extracellular matrix digestion. Circ Res. 1994; 75:181-189.
12. Woessner JF. Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J. 1991;5:2145-2154.
13. Apte SS, Olsen BR, Murphy G. The gene structure of tissue inhibitor of metalloproteinases (TIMPJ-3 and its inhibitory activities define the distinct TIMP gene family. J Biol Chem. 1995; 270:14313-14318.
14. Leco KJ, Khokha R, Pavloff N, Hawkes SP, Edwards DR. Tissue innibitor of metalloproteinase-3 (TIMP-3) is an extracellular matrix-associated protein with a distinctive pattern of expression in mouse cells and tissues. J Biol Chem. 1994;269:9352-9360.
15. Gospodarowicz D. Fibroblast growth factor. Crit Rev Oncog. 1989; 1:1-26.
16. Folkman J, Klagsbrun M. Angiogenic factors. Science. 1987;235: 442-447.